Healthcare Industry News: computer-aided detection
News Release - September 13, 2010
Riverain Medical Appoints Rich Bares Executive Vice President of Sales and MarketingDAYTON, Ohio--(Healthcare Sales & Marketing Network)--Riverain Medical, an industry leader and innovator in computer-aided detection (CAD) and advanced visualization technologies, today announced it has appointed Rich Bares as Executive Vice President, Sales and Marketing. In this role, Mr. Bares will be responsible for the global go-to-market and support strategies for the company.
Mr. Bares has more than 25 years experience in the medical imaging and medical software industry. Most recently he was Executive Vice President of Acuitec, LLC, an early-stage company focused on commercializing peroperative software. In this position he was responsible for establishing and building the sales process, cultivating strategic partnerships, and working with members of Acuitec’s team to create offerings that address technological needs within the market. He previously held management positions at Agfa Healthcare, GE Healthcare, Toshiba Medical Systems, and ISG Technologies. Mr. Bares holds a Bachelors Degree in Business Administration from Laras College in Dubuque, Iowa, and a Masters of Business Administration from the University of Colorado in Denver, Colo.
“With the recent FDA-clearance of SoftView and FDA-approval of OnGuard, it is an exciting time to be joining Riverain Medical,” said Rich Bares, Executive Vice President, Sales and Marketing for Riverain Medical. “I look forward to building on this momentum and working closely with the executive team and our sales and marketing team to bring our latest products to radiologists.”
Riverain Medical is a Dayton, Ohio-based medical technology innovator that develops practical solutions to save and improve the quality of people’s lives, through the early detection of disease. The Company’s technologies are designed to enhance the expert skills of physicians to improve patient outcomes without additional radiation dose or procedures. For more information please visit: http://www.riverainmedical.com.
Source: Riverain Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.